A number of research firms have changed their ratings and price targets for Oncology Institute (NASDAQ: STLN):
- 11/6/2026 – Oncology Institute had its price target lowered by Lake Street Capital from $10.00 to $8.00. They now have a “buy” rating on the stock.
- 11/6/2026 – Oncology Institute had its “buy” rating reaffirmed by B. Riley Financial. They now have a $10.00 price target on the stock, down from $11.00.
- 11/6/2026 – Oncology Institute had its price target raised by BTIG Research from $9.00 to $10.00. They now have a “buy” rating on the stock.
- 11/3/2026 – Oncology Institute had its “sell (d-)” rating reaffirmed by Weiss Ratings.
- 10/14/2026 – Oncology Institute had its price target raised by Needham & Company LLC from $7.00 to $9.00. They now have a “buy” rating on the stock.
Oncology Institute Stock Performance
STLN stock opened at $3.20 on Thursday. Oncology Institute, Inc. has a fifty-two week low of $2.32 and a fifty-two week high of $7.13. The company has a market capitalization of $326.37 million, a P/E ratio of -11.03 and a beta of 0.44. The firm has a 50-day moving average price of $6.06.
Oncology Institute (NASDAQ:STLN – Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The company reported ($0.13) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.07) by ($0.06). The business had revenue of $169.77 million during the quarter. On average, sell-side analysts anticipate that Oncology Institute, Inc. will post -0.27 EPS for the current year.
Insider Activity at Oncology Institute
The Oncology Institute is a physician-led provider of cancer care. Its services include medical oncology and hematology consultations, cancer treatment and infusion services, pharmacy support, and access to clinical trials. The company combines community-based clinics with care coordination and value-based care programs intended to support patients throughout treatment. It serves patients in several U.S. states, including California, Nevada, Arizona, and Florida. Founded in 2007, The Oncology Institute has expanded its network of oncology clinics and related services to provide cancer care closer to where patients live.
Read More
- Five stocks we like better than Oncology Institute
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Receive News & Ratings for Oncology Institute Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncology Institute Inc and related companies with MarketBeat.com's FREE daily email newsletter.
